Skip to content

Effect of Kinesiotaping Application in Preterm Infants Undergoing Noninvasive Ventilation

Effect of Kinesiotaping Applications on Diaphragm, Abdomen and Chest Wall in Preterm Infants Undergoing Noninvasive Ventilation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03660358
Enrollment
42
Registered
2018-09-06
Start date
2018-05-01
Completion date
2019-05-01
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Infant

Keywords

preterm infants, kinesiotape, ventilation, respiratory muscles

Brief summary

Kinesiotaping (KT) applied to the thorax is believed to enhance breathing by supporting the respiratory muscles. Infants born premature usually have respiratory problems because of depletion of surfactant and respiratory muscle weakness. Therefore, we are going to use KT for premature infants in NICU who are undergoing non-invasive ventilation. Forty-two participants divided into two groups. The first group will be applied KT to chest wall, abdomen and diaphragm, and the other group will not receive any KT application during non-invasive ventilation. KT application will be going on as long as the infant underwent non-invasive ventilation. We are going to measure blood gas parameters (pH, pCO2, pO2, base excess), respiration rate, peak heart rate, percentage of Fio2, FiO2/pO2 rate, PEEP and PIP values before non-invasive ventilation, 2 hours after non-invasive ventilation, within 72 hours and shortly before weaning from non-invasive ventilation.

Interventions

kinesiotape application to diaphragm, chest wall and abdomen in preterm infants.

Sponsors

Baskent University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
24 Weeks to 36 Weeks
Healthy volunteers
No

Inclusion criteria

* Inpatient infants in NICU, born in Baskent University Ankara Hospital, undergoing non-invasive ventilation and age between 24-36.6 weeks.

Exclusion criteria

* Infants with multiple kongenital anomaly, hypoxic ischemic encephalopathy, tracheoesophageal fistula, diaphragmatic hernia.

Design outcomes

Primary

MeasureTime frameDescription
arterial blood gas1 dayarterial blood gas

Countries

Turkey (Türkiye)

Contacts

Primary ContactNilay Comuk Balci, Pt, PhD
nlycmk@yahoo.com+905067115879
Backup ContactAyse Ecevit, MD
ayseecevit@yahoo.com+905348937200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026